Resonancia magnética, histología y genética | 09 FEB 20
Evaluación de tumores lipomatosos profundos
El objetivo de este estudio fue reportar una serie de tumores lipomatosos profundos de una única institución con análisis del gen MDM2, examinando la frecuencia del tumor lipomatoso atipico, y comparando las características clínicas, radiológicas y anatomopatológicas de los tumores lipomatosos atípicos y los lipomas, para diferenciar entre esos tipos tumorales
Autor/a: Cairncross L, Snow HA , Strauss DC, Smith MJF, Sjokvist O y colaboradores Br J Surg 2019; 106(13): 1794-1799
Página 1
- Dalal KM, Antonescu CR, Singer S. Diagnosis and management of lipomatous tumors. J Surg Oncol 2008; 97: 298–313.
- McTighe S, Chernev I. Intramuscular lipoma: a review of the literature. Orthop Rev (Pavia) 2014; 6: 5618.
- Fisher SB, Baxter KJ, Staley CA III, Fisher KE, Monson DK, Murray DR et al. The General Surgeon’s quandary: atypical lipomatous tumor vs lipoma, who needs a surgical oncologist? J Am Coll Surg 2013; 217: 881–888.
- Fletcher CDM,World Health Organization; International Agency for Research on Cancer. WHO Classification of Tumours of Soft Tissue and Bone (4th edn). IARC Press: Lyon, 2013.
- Kammerer-Jacquet SF, Thierry S, Cabillic F, Lannes M, Burtin F, Henno S et al. Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry. Hum Pathol 2017; 59: 34–40.
- Laurino L, Furlanetto A, Orvieto E, Dei Tos AP. Well-differentiated liposarcoma (atypical lipomatous tumors). Semin Diagn Pathol 2001; 18: 258–262.
- Myhre-Jensen O. A consecutive 7-year series of 1331 benign soft tissue tumours. Clinicopathologic data. Comparison with sarcomas. Acta Orthop Scand 1981; 52: 287–293.
- Clay MR, Martinez AP,Weiss SW, Edgar MA. MDM2 amplification in problematic lipomatous tumors: analysis of FISH testing criteria. Am J Surg Pathol 2015; 39: 1433–1439.
- Thway K,Wang J, Swansbury J, Min T, Fisher C. Fluorescence in situ hybridization for MDM2 amplification as a routine ancillary diagnostic tool for suspected well-differentiated and dedifferentiated liposarcomas: experience at a tertiary center. Sarcoma 2015; 2015: 812089.
- Zhang H, Erickson-Johnson M,Wang X, Oliveira JL, Nascimento AG, Sim FH et al. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors. Am J Surg Pathol 2
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024